On December 4 last year, the stock of the world's largest drugmaker, Pfizer, fell 10.6 per cent, wiping out more than $21 billion in market value in a single day.
The yorker that cleaned up Ollie Pope's stumps on Saturday, February 3, 2024 on Day 2 of the second England-India Test at the Dr Y S Rajasekhara Reddy ACA-VDCA cricket stadium in Visakhapatnam.
The markets opened firm on Tuesday and crossed the 7,800 mark after opening with a gain of 7 points at 7,774.
"It is unrealistic to expect that COVID-19 pandemic can be eliminated at this stage given that community transmission is already well-established across large sections or sub-populations in the country," the report said.
Is it about how to end the wrestlers' stand-off?
The government should take measures to promote innovation and R&D while simplifying regulations for the sector in the upcoming Union Budget, as per pharmaceutical industry bodies. Outlining the wish list for the sector in the upcoming Union Budget, Indian Pharmaceutical Alliance (IPA) secretary general Sudarshan Jain said the domestic pharma industry is currently around $50 billion in size and aspires to grow to around $130 billion by 2030 and $450 billion by 2047. "To achieve this vision, the Union Budget 2023-2024 should help fuel innovation and R&D, which will set the pace for propelling the pharmaceutical industry forward," he told PTI.
Reddy stated that KCR's statement on proposing a new constitution is an extension of the idea of the BJP.
Domestic pharma giant Ranbaxy Laboratories Limited has topped the list of patent filers in the area of drug applications from the Third World countries last year with 64 new formulations.\n\n\n\n
US markets have been very lucrative for the Indian pharma companies and many companies such as Ranbaxy and Dr Reddy's capitalised on this opportunity.
The Sensex closed up 22.50 points or 0.16% at 13,703.33, and the Nifty up 5.40 points or 0.14% at 3950.85.
The markets opened in the positive terrain but slipped and are trading flat as selling was seen in banking and pharma stocks
The Sensex slipped into negative territory, after opening 14 points up at 7,765.
The markets opened strong on F&O expiry today despite some mixed global cues
Equity benchmarks continued their winning momentum for the third day on Thursday and jumped over 1.50 per cent, tracking an overall bullish trend in Asian equities. On the political front, the BJP headed for a second straight win in politically crucial Uttar Pradesh and dominated the trends chart in three other states. The 30-share BSE benchmark Sensex opened in the green and further zoomed 1,595.14 points or 2.91 per cent to 56,242.47 during early trade.
Investor wealth has jumped by over Rs 12.31 lakh crore in three days, taking the market capitalisation of all BSE-listed companies to a record Rs 198.43 lakh crore on Wednesday as equities continued their Budget-driven rally. The BSE benchmark Sensex closed above the historic 50,000 mark for the first time ever on Wednesday. The 30-share benchmark closed with a gain of 458.03 points or 0.92 per cent at 50,255.75. During the day, it zoomed 728.67 points to its lifetime high of 50,526.39. In three trading days, the benchmark has gained 3,969.98 points or 8.57 per cent.
Over the last five days, Modi visited all of south, held roadshows, made an aggressive bid for his party, and took on the rivals with full gusto, especially the ruling Dravida Munnetra Kazhagam in Tamil Nadu, and the Bharat Rashtra Samithi in Telangana that was in power for 10 years.
The Nifty gained 47 points to close at 3,605.\n\n
Nifty PSU Bank index gained 1% led by Allahabad Bank, Andhra Bank, Syndicate Bank and IDBI Bank
Cricket climate change to medical practice, dropped candidates have their non-political life sorted.
Cipla is recalling the drug for failed impurities and degradation specifications.
Growth has been under pressure since the lockdowns related to Covid-19 started and fresh prescription generations slowed.
Addressing a press briefing, Union Health Secretary Rajesh Bhushan said Zydus Cadila, Sputnik V, Biological E and Gennova are other vaccines also in the pipeline which are in advanced clinical trials in India.
The Sensex opened past the 8,200-mark at 8,208 as against Wednesday's close of 8,189 and later rallied smartly to a high of 8,252.
With rains once again lashing Mumbai, the Sensex opened weak and is now down 20 points at 7616. Nifty is down 8 points at 2304.
Equity indices made an emphatic comeback on Friday after falling for seven straight sessions after the RBI hiked interest rates by 50 basis points on expected lines and projected inflation coming under control from January next year. A strong recovery in the rupee added to the momentum, traders said. Overcoming a wobbly start, the 30-share BSE Sensex soared 1,016.96 points or 1.80 per cent to settle at 57,426.92. During the day, it rallied 1,312.67 points or 2.32 per cent to 57,722.63.
Eminent Indian-American attorney from New York Ravi Batra has termed it a "dead on arrival lawsuit".
L&T was the top gainer in the Sensex pack, rising over 3 per cent, followed by Bajaj Finance, Reliance Industries, IndusInd Bank, SBI and HDFC Bank. NSE Nifty surged 168.05 points to 14,653.05.
